Inspira Health Network - Medicare Primary Care in Glassboro, NJ

Inspira Health Network is a medicare enrolled primary clinic (Clinic/center - Multi-specialty) in Glassboro, New Jersey. The current practice location for Inspira Health Network is 1120 Delsea Dr N, Glassboro, New Jersey. For appointments, you can reach them via phone at (856) 205-7071. The mailing address for Inspira Health Network is 1120 Delsea Dr N, Glassboro, New Jersey and phone number is (856) 205-7071.

Inspira Health Network is licensed to practice in * (Not Available) (license number ). The clinic also participates in the medicare program and its NPI number is 1124660501. This medical practice accepts medicare insurance (which means this clinic accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance). However, please confirm if they accept your insurance at (856) 205-7071.

Contact Information

Inspira Health Network
1120 Delsea Dr N
Glassboro
NJ 08028-1444
(856) 205-7071
Not Available

Primary Care Clinic Profile

Full NameInspira Health Network
SpecialityClinic/Center
Location1120 Delsea Dr N, Glassboro, New Jersey
Authorized Official Name and PositionGeralyn Paterson (VP)
Authorized Official Contact8562057070
Accepts Medicare InsuranceYes. This clinic participates in medicare program and accept medicare insurance.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Inspira Health Network
1120 Delsea Dr N
Glassboro
NJ 08028-1444

Ph: (856) 205-7071
Inspira Health Network
1120 Delsea Dr N
Glassboro
NJ 08028-1444

Ph: (856) 205-7071

NPI Details:

NPI Number1124660501
Provider Enumeration Date10/17/2019
Last Update Date10/17/2019

Medicare PECOS Information:

Medicare PECOS PAC ID8022271410
Medicare Enrollment IDO20120522001234

News Archive

Leading organizations call for responsible use of antibiotics to combat rising drug resistance

In the lead-up to World Antibiotic Awareness Week (13-19 November 2017), the Food and Agriculture Organization of the United Nations, the World Health Organization and the World Organisation for Animal Health are together calling for responsible use of antibiotics in humans and animals to reduce the emergence of antibiotic resistance.

Uroglide technology could improve comfort for catheter users

A new pharmaceutical product that could significantly improve quality of life for catheter users all over the world is to be developed by Queen's University Belfast after it won a national award.

Conference reviews effects of tobacco products, underscores the importance of oral health

On September 14, 2018 AADR held the "Oral Health Effects of Tobacco Products: Science and Regulatory Policy" meeting in Bethesda, Maryland, USA.

Study proves the effectiveness of Vfend for the treatment of candidemia

Using Vfend (voriconazole) for the treatment of nonneutropenic patients with candidemia, an often-fatal hospital-acquired bloodstream infection, is as effective as a regimen of two older antifungals and carries fewer serious side effects than that regimen.

Scalp cooling technology to fight cancer causing alopecia (hair loss) approved by the FDA

Paxman Coolers Limited announced today that The U.S. Food and Drug Administration (FDA) has cleared the company to market the Paxman Scalp Cooling System, a scalp cooling technology that was developed by a British family to reduce hair loss in breast cancer patients undergoing chemotherapy.

Read more Medical News

› Verified 6 days ago

Medical Identifiers

Medical identifiers for Inspira Health Network such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1124660501NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
261QM1300XClinic/center - Multi-specialty (* (Not Available))Primary

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Inspira Health Network acts as a billing entity for following providers:
Provider NameJohn J Gartland
Provider TypePractitioner - Family Practice
Provider IdentifiersNPI Number: 1417045030
PECOS PAC ID: 6103712617
Enrollment ID: I20040223000875

News Archive

Leading organizations call for responsible use of antibiotics to combat rising drug resistance

In the lead-up to World Antibiotic Awareness Week (13-19 November 2017), the Food and Agriculture Organization of the United Nations, the World Health Organization and the World Organisation for Animal Health are together calling for responsible use of antibiotics in humans and animals to reduce the emergence of antibiotic resistance.

Uroglide technology could improve comfort for catheter users

A new pharmaceutical product that could significantly improve quality of life for catheter users all over the world is to be developed by Queen's University Belfast after it won a national award.

Conference reviews effects of tobacco products, underscores the importance of oral health

On September 14, 2018 AADR held the "Oral Health Effects of Tobacco Products: Science and Regulatory Policy" meeting in Bethesda, Maryland, USA.

Study proves the effectiveness of Vfend for the treatment of candidemia

Using Vfend (voriconazole) for the treatment of nonneutropenic patients with candidemia, an often-fatal hospital-acquired bloodstream infection, is as effective as a regimen of two older antifungals and carries fewer serious side effects than that regimen.

Scalp cooling technology to fight cancer causing alopecia (hair loss) approved by the FDA

Paxman Coolers Limited announced today that The U.S. Food and Drug Administration (FDA) has cleared the company to market the Paxman Scalp Cooling System, a scalp cooling technology that was developed by a British family to reduce hair loss in breast cancer patients undergoing chemotherapy.

Read more Medical News

› Verified 6 days ago

Provider NameMarisa Cinalli
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1659323822
PECOS PAC ID: 9032171269
Enrollment ID: I20041101000130

News Archive

Leading organizations call for responsible use of antibiotics to combat rising drug resistance

In the lead-up to World Antibiotic Awareness Week (13-19 November 2017), the Food and Agriculture Organization of the United Nations, the World Health Organization and the World Organisation for Animal Health are together calling for responsible use of antibiotics in humans and animals to reduce the emergence of antibiotic resistance.

Uroglide technology could improve comfort for catheter users

A new pharmaceutical product that could significantly improve quality of life for catheter users all over the world is to be developed by Queen's University Belfast after it won a national award.

Conference reviews effects of tobacco products, underscores the importance of oral health

On September 14, 2018 AADR held the "Oral Health Effects of Tobacco Products: Science and Regulatory Policy" meeting in Bethesda, Maryland, USA.

Study proves the effectiveness of Vfend for the treatment of candidemia

Using Vfend (voriconazole) for the treatment of nonneutropenic patients with candidemia, an often-fatal hospital-acquired bloodstream infection, is as effective as a regimen of two older antifungals and carries fewer serious side effects than that regimen.

Scalp cooling technology to fight cancer causing alopecia (hair loss) approved by the FDA

Paxman Coolers Limited announced today that The U.S. Food and Drug Administration (FDA) has cleared the company to market the Paxman Scalp Cooling System, a scalp cooling technology that was developed by a British family to reduce hair loss in breast cancer patients undergoing chemotherapy.

Read more Medical News

› Verified 6 days ago

Provider NameJoseph J Conti
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1679552921
PECOS PAC ID: 2961497649
Enrollment ID: I20041101000202

News Archive

Leading organizations call for responsible use of antibiotics to combat rising drug resistance

In the lead-up to World Antibiotic Awareness Week (13-19 November 2017), the Food and Agriculture Organization of the United Nations, the World Health Organization and the World Organisation for Animal Health are together calling for responsible use of antibiotics in humans and animals to reduce the emergence of antibiotic resistance.

Uroglide technology could improve comfort for catheter users

A new pharmaceutical product that could significantly improve quality of life for catheter users all over the world is to be developed by Queen's University Belfast after it won a national award.

Conference reviews effects of tobacco products, underscores the importance of oral health

On September 14, 2018 AADR held the "Oral Health Effects of Tobacco Products: Science and Regulatory Policy" meeting in Bethesda, Maryland, USA.

Study proves the effectiveness of Vfend for the treatment of candidemia

Using Vfend (voriconazole) for the treatment of nonneutropenic patients with candidemia, an often-fatal hospital-acquired bloodstream infection, is as effective as a regimen of two older antifungals and carries fewer serious side effects than that regimen.

Scalp cooling technology to fight cancer causing alopecia (hair loss) approved by the FDA

Paxman Coolers Limited announced today that The U.S. Food and Drug Administration (FDA) has cleared the company to market the Paxman Scalp Cooling System, a scalp cooling technology that was developed by a British family to reduce hair loss in breast cancer patients undergoing chemotherapy.

Read more Medical News

› Verified 6 days ago

Provider NameJen Lih Kou
Provider TypePractitioner - Geriatric Medicine
Provider IdentifiersNPI Number: 1386731354
PECOS PAC ID: 6002842234
Enrollment ID: I20050711000546

News Archive

Leading organizations call for responsible use of antibiotics to combat rising drug resistance

In the lead-up to World Antibiotic Awareness Week (13-19 November 2017), the Food and Agriculture Organization of the United Nations, the World Health Organization and the World Organisation for Animal Health are together calling for responsible use of antibiotics in humans and animals to reduce the emergence of antibiotic resistance.

Uroglide technology could improve comfort for catheter users

A new pharmaceutical product that could significantly improve quality of life for catheter users all over the world is to be developed by Queen's University Belfast after it won a national award.

Conference reviews effects of tobacco products, underscores the importance of oral health

On September 14, 2018 AADR held the "Oral Health Effects of Tobacco Products: Science and Regulatory Policy" meeting in Bethesda, Maryland, USA.

Study proves the effectiveness of Vfend for the treatment of candidemia

Using Vfend (voriconazole) for the treatment of nonneutropenic patients with candidemia, an often-fatal hospital-acquired bloodstream infection, is as effective as a regimen of two older antifungals and carries fewer serious side effects than that regimen.

Scalp cooling technology to fight cancer causing alopecia (hair loss) approved by the FDA

Paxman Coolers Limited announced today that The U.S. Food and Drug Administration (FDA) has cleared the company to market the Paxman Scalp Cooling System, a scalp cooling technology that was developed by a British family to reduce hair loss in breast cancer patients undergoing chemotherapy.

Read more Medical News

› Verified 6 days ago

Provider NameIra M Cuttler
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1760462766
PECOS PAC ID: 8628051372
Enrollment ID: I20050713000705

News Archive

Leading organizations call for responsible use of antibiotics to combat rising drug resistance

In the lead-up to World Antibiotic Awareness Week (13-19 November 2017), the Food and Agriculture Organization of the United Nations, the World Health Organization and the World Organisation for Animal Health are together calling for responsible use of antibiotics in humans and animals to reduce the emergence of antibiotic resistance.

Uroglide technology could improve comfort for catheter users

A new pharmaceutical product that could significantly improve quality of life for catheter users all over the world is to be developed by Queen's University Belfast after it won a national award.

Conference reviews effects of tobacco products, underscores the importance of oral health

On September 14, 2018 AADR held the "Oral Health Effects of Tobacco Products: Science and Regulatory Policy" meeting in Bethesda, Maryland, USA.

Study proves the effectiveness of Vfend for the treatment of candidemia

Using Vfend (voriconazole) for the treatment of nonneutropenic patients with candidemia, an often-fatal hospital-acquired bloodstream infection, is as effective as a regimen of two older antifungals and carries fewer serious side effects than that regimen.

Scalp cooling technology to fight cancer causing alopecia (hair loss) approved by the FDA

Paxman Coolers Limited announced today that The U.S. Food and Drug Administration (FDA) has cleared the company to market the Paxman Scalp Cooling System, a scalp cooling technology that was developed by a British family to reduce hair loss in breast cancer patients undergoing chemotherapy.

Read more Medical News

› Verified 6 days ago

Provider NameChristine Marie Surrey
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1972583540
PECOS PAC ID: 9234165689
Enrollment ID: I20050718000031

News Archive

Leading organizations call for responsible use of antibiotics to combat rising drug resistance

In the lead-up to World Antibiotic Awareness Week (13-19 November 2017), the Food and Agriculture Organization of the United Nations, the World Health Organization and the World Organisation for Animal Health are together calling for responsible use of antibiotics in humans and animals to reduce the emergence of antibiotic resistance.

Uroglide technology could improve comfort for catheter users

A new pharmaceutical product that could significantly improve quality of life for catheter users all over the world is to be developed by Queen's University Belfast after it won a national award.

Conference reviews effects of tobacco products, underscores the importance of oral health

On September 14, 2018 AADR held the "Oral Health Effects of Tobacco Products: Science and Regulatory Policy" meeting in Bethesda, Maryland, USA.

Study proves the effectiveness of Vfend for the treatment of candidemia

Using Vfend (voriconazole) for the treatment of nonneutropenic patients with candidemia, an often-fatal hospital-acquired bloodstream infection, is as effective as a regimen of two older antifungals and carries fewer serious side effects than that regimen.

Scalp cooling technology to fight cancer causing alopecia (hair loss) approved by the FDA

Paxman Coolers Limited announced today that The U.S. Food and Drug Administration (FDA) has cleared the company to market the Paxman Scalp Cooling System, a scalp cooling technology that was developed by a British family to reduce hair loss in breast cancer patients undergoing chemotherapy.

Read more Medical News

› Verified 6 days ago

Provider NameDonald C Huston
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1316973563
PECOS PAC ID: 4981655735
Enrollment ID: I20060117000709

News Archive

Leading organizations call for responsible use of antibiotics to combat rising drug resistance

In the lead-up to World Antibiotic Awareness Week (13-19 November 2017), the Food and Agriculture Organization of the United Nations, the World Health Organization and the World Organisation for Animal Health are together calling for responsible use of antibiotics in humans and animals to reduce the emergence of antibiotic resistance.

Uroglide technology could improve comfort for catheter users

A new pharmaceutical product that could significantly improve quality of life for catheter users all over the world is to be developed by Queen's University Belfast after it won a national award.

Conference reviews effects of tobacco products, underscores the importance of oral health

On September 14, 2018 AADR held the "Oral Health Effects of Tobacco Products: Science and Regulatory Policy" meeting in Bethesda, Maryland, USA.

Study proves the effectiveness of Vfend for the treatment of candidemia

Using Vfend (voriconazole) for the treatment of nonneutropenic patients with candidemia, an often-fatal hospital-acquired bloodstream infection, is as effective as a regimen of two older antifungals and carries fewer serious side effects than that regimen.

Scalp cooling technology to fight cancer causing alopecia (hair loss) approved by the FDA

Paxman Coolers Limited announced today that The U.S. Food and Drug Administration (FDA) has cleared the company to market the Paxman Scalp Cooling System, a scalp cooling technology that was developed by a British family to reduce hair loss in breast cancer patients undergoing chemotherapy.

Read more Medical News

› Verified 6 days ago

Provider NameQue-chi Wong
Provider TypePractitioner - Family Practice
Provider IdentifiersNPI Number: 1558314641
PECOS PAC ID: 7911978101
Enrollment ID: I20060621000039

News Archive

Leading organizations call for responsible use of antibiotics to combat rising drug resistance

In the lead-up to World Antibiotic Awareness Week (13-19 November 2017), the Food and Agriculture Organization of the United Nations, the World Health Organization and the World Organisation for Animal Health are together calling for responsible use of antibiotics in humans and animals to reduce the emergence of antibiotic resistance.

Uroglide technology could improve comfort for catheter users

A new pharmaceutical product that could significantly improve quality of life for catheter users all over the world is to be developed by Queen's University Belfast after it won a national award.

Conference reviews effects of tobacco products, underscores the importance of oral health

On September 14, 2018 AADR held the "Oral Health Effects of Tobacco Products: Science and Regulatory Policy" meeting in Bethesda, Maryland, USA.

Study proves the effectiveness of Vfend for the treatment of candidemia

Using Vfend (voriconazole) for the treatment of nonneutropenic patients with candidemia, an often-fatal hospital-acquired bloodstream infection, is as effective as a regimen of two older antifungals and carries fewer serious side effects than that regimen.

Scalp cooling technology to fight cancer causing alopecia (hair loss) approved by the FDA

Paxman Coolers Limited announced today that The U.S. Food and Drug Administration (FDA) has cleared the company to market the Paxman Scalp Cooling System, a scalp cooling technology that was developed by a British family to reduce hair loss in breast cancer patients undergoing chemotherapy.

Read more Medical News

› Verified 6 days ago

Provider NameBarry G Nixon
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1811044910
PECOS PAC ID: 3476654658
Enrollment ID: I20070719000074

News Archive

Leading organizations call for responsible use of antibiotics to combat rising drug resistance

In the lead-up to World Antibiotic Awareness Week (13-19 November 2017), the Food and Agriculture Organization of the United Nations, the World Health Organization and the World Organisation for Animal Health are together calling for responsible use of antibiotics in humans and animals to reduce the emergence of antibiotic resistance.

Uroglide technology could improve comfort for catheter users

A new pharmaceutical product that could significantly improve quality of life for catheter users all over the world is to be developed by Queen's University Belfast after it won a national award.

Conference reviews effects of tobacco products, underscores the importance of oral health

On September 14, 2018 AADR held the "Oral Health Effects of Tobacco Products: Science and Regulatory Policy" meeting in Bethesda, Maryland, USA.

Study proves the effectiveness of Vfend for the treatment of candidemia

Using Vfend (voriconazole) for the treatment of nonneutropenic patients with candidemia, an often-fatal hospital-acquired bloodstream infection, is as effective as a regimen of two older antifungals and carries fewer serious side effects than that regimen.

Scalp cooling technology to fight cancer causing alopecia (hair loss) approved by the FDA

Paxman Coolers Limited announced today that The U.S. Food and Drug Administration (FDA) has cleared the company to market the Paxman Scalp Cooling System, a scalp cooling technology that was developed by a British family to reduce hair loss in breast cancer patients undergoing chemotherapy.

Read more Medical News

› Verified 6 days ago

Provider NameValerie Schiano
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1194823880
PECOS PAC ID: 6800980095
Enrollment ID: I20070919000277

News Archive

Leading organizations call for responsible use of antibiotics to combat rising drug resistance

In the lead-up to World Antibiotic Awareness Week (13-19 November 2017), the Food and Agriculture Organization of the United Nations, the World Health Organization and the World Organisation for Animal Health are together calling for responsible use of antibiotics in humans and animals to reduce the emergence of antibiotic resistance.

Uroglide technology could improve comfort for catheter users

A new pharmaceutical product that could significantly improve quality of life for catheter users all over the world is to be developed by Queen's University Belfast after it won a national award.

Conference reviews effects of tobacco products, underscores the importance of oral health

On September 14, 2018 AADR held the "Oral Health Effects of Tobacco Products: Science and Regulatory Policy" meeting in Bethesda, Maryland, USA.

Study proves the effectiveness of Vfend for the treatment of candidemia

Using Vfend (voriconazole) for the treatment of nonneutropenic patients with candidemia, an often-fatal hospital-acquired bloodstream infection, is as effective as a regimen of two older antifungals and carries fewer serious side effects than that regimen.

Scalp cooling technology to fight cancer causing alopecia (hair loss) approved by the FDA

Paxman Coolers Limited announced today that The U.S. Food and Drug Administration (FDA) has cleared the company to market the Paxman Scalp Cooling System, a scalp cooling technology that was developed by a British family to reduce hair loss in breast cancer patients undergoing chemotherapy.

Read more Medical News

› Verified 6 days ago

Provider NameShanthi Subbiah
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1104897370
PECOS PAC ID: 5597794446
Enrollment ID: I20071228000065

News Archive

Leading organizations call for responsible use of antibiotics to combat rising drug resistance

In the lead-up to World Antibiotic Awareness Week (13-19 November 2017), the Food and Agriculture Organization of the United Nations, the World Health Organization and the World Organisation for Animal Health are together calling for responsible use of antibiotics in humans and animals to reduce the emergence of antibiotic resistance.

Uroglide technology could improve comfort for catheter users

A new pharmaceutical product that could significantly improve quality of life for catheter users all over the world is to be developed by Queen's University Belfast after it won a national award.

Conference reviews effects of tobacco products, underscores the importance of oral health

On September 14, 2018 AADR held the "Oral Health Effects of Tobacco Products: Science and Regulatory Policy" meeting in Bethesda, Maryland, USA.

Study proves the effectiveness of Vfend for the treatment of candidemia

Using Vfend (voriconazole) for the treatment of nonneutropenic patients with candidemia, an often-fatal hospital-acquired bloodstream infection, is as effective as a regimen of two older antifungals and carries fewer serious side effects than that regimen.

Scalp cooling technology to fight cancer causing alopecia (hair loss) approved by the FDA

Paxman Coolers Limited announced today that The U.S. Food and Drug Administration (FDA) has cleared the company to market the Paxman Scalp Cooling System, a scalp cooling technology that was developed by a British family to reduce hair loss in breast cancer patients undergoing chemotherapy.

Read more Medical News

› Verified 6 days ago

Provider NameAlyson Emmons
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1891733010
PECOS PAC ID: 0840377628
Enrollment ID: I20091020000632

News Archive

Leading organizations call for responsible use of antibiotics to combat rising drug resistance

In the lead-up to World Antibiotic Awareness Week (13-19 November 2017), the Food and Agriculture Organization of the United Nations, the World Health Organization and the World Organisation for Animal Health are together calling for responsible use of antibiotics in humans and animals to reduce the emergence of antibiotic resistance.

Uroglide technology could improve comfort for catheter users

A new pharmaceutical product that could significantly improve quality of life for catheter users all over the world is to be developed by Queen's University Belfast after it won a national award.

Conference reviews effects of tobacco products, underscores the importance of oral health

On September 14, 2018 AADR held the "Oral Health Effects of Tobacco Products: Science and Regulatory Policy" meeting in Bethesda, Maryland, USA.

Study proves the effectiveness of Vfend for the treatment of candidemia

Using Vfend (voriconazole) for the treatment of nonneutropenic patients with candidemia, an often-fatal hospital-acquired bloodstream infection, is as effective as a regimen of two older antifungals and carries fewer serious side effects than that regimen.

Scalp cooling technology to fight cancer causing alopecia (hair loss) approved by the FDA

Paxman Coolers Limited announced today that The U.S. Food and Drug Administration (FDA) has cleared the company to market the Paxman Scalp Cooling System, a scalp cooling technology that was developed by a British family to reduce hair loss in breast cancer patients undergoing chemotherapy.

Read more Medical News

› Verified 6 days ago

Provider NameErin M Chini
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1609013267
PECOS PAC ID: 9335295732
Enrollment ID: I20100407000124

News Archive

Leading organizations call for responsible use of antibiotics to combat rising drug resistance

In the lead-up to World Antibiotic Awareness Week (13-19 November 2017), the Food and Agriculture Organization of the United Nations, the World Health Organization and the World Organisation for Animal Health are together calling for responsible use of antibiotics in humans and animals to reduce the emergence of antibiotic resistance.

Uroglide technology could improve comfort for catheter users

A new pharmaceutical product that could significantly improve quality of life for catheter users all over the world is to be developed by Queen's University Belfast after it won a national award.

Conference reviews effects of tobacco products, underscores the importance of oral health

On September 14, 2018 AADR held the "Oral Health Effects of Tobacco Products: Science and Regulatory Policy" meeting in Bethesda, Maryland, USA.

Study proves the effectiveness of Vfend for the treatment of candidemia

Using Vfend (voriconazole) for the treatment of nonneutropenic patients with candidemia, an often-fatal hospital-acquired bloodstream infection, is as effective as a regimen of two older antifungals and carries fewer serious side effects than that regimen.

Scalp cooling technology to fight cancer causing alopecia (hair loss) approved by the FDA

Paxman Coolers Limited announced today that The U.S. Food and Drug Administration (FDA) has cleared the company to market the Paxman Scalp Cooling System, a scalp cooling technology that was developed by a British family to reduce hair loss in breast cancer patients undergoing chemotherapy.

Read more Medical News

› Verified 6 days ago

Provider NameTheresa A Soutar
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1790737963
PECOS PAC ID: 5597721100
Enrollment ID: I20100623000709

News Archive

Leading organizations call for responsible use of antibiotics to combat rising drug resistance

In the lead-up to World Antibiotic Awareness Week (13-19 November 2017), the Food and Agriculture Organization of the United Nations, the World Health Organization and the World Organisation for Animal Health are together calling for responsible use of antibiotics in humans and animals to reduce the emergence of antibiotic resistance.

Uroglide technology could improve comfort for catheter users

A new pharmaceutical product that could significantly improve quality of life for catheter users all over the world is to be developed by Queen's University Belfast after it won a national award.

Conference reviews effects of tobacco products, underscores the importance of oral health

On September 14, 2018 AADR held the "Oral Health Effects of Tobacco Products: Science and Regulatory Policy" meeting in Bethesda, Maryland, USA.

Study proves the effectiveness of Vfend for the treatment of candidemia

Using Vfend (voriconazole) for the treatment of nonneutropenic patients with candidemia, an often-fatal hospital-acquired bloodstream infection, is as effective as a regimen of two older antifungals and carries fewer serious side effects than that regimen.

Scalp cooling technology to fight cancer causing alopecia (hair loss) approved by the FDA

Paxman Coolers Limited announced today that The U.S. Food and Drug Administration (FDA) has cleared the company to market the Paxman Scalp Cooling System, a scalp cooling technology that was developed by a British family to reduce hair loss in breast cancer patients undergoing chemotherapy.

Read more Medical News

› Verified 6 days ago

Provider NameMaurice S Sheetz
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1902832157
PECOS PAC ID: 1456302207
Enrollment ID: I20100914000868

News Archive

Leading organizations call for responsible use of antibiotics to combat rising drug resistance

In the lead-up to World Antibiotic Awareness Week (13-19 November 2017), the Food and Agriculture Organization of the United Nations, the World Health Organization and the World Organisation for Animal Health are together calling for responsible use of antibiotics in humans and animals to reduce the emergence of antibiotic resistance.

Uroglide technology could improve comfort for catheter users

A new pharmaceutical product that could significantly improve quality of life for catheter users all over the world is to be developed by Queen's University Belfast after it won a national award.

Conference reviews effects of tobacco products, underscores the importance of oral health

On September 14, 2018 AADR held the "Oral Health Effects of Tobacco Products: Science and Regulatory Policy" meeting in Bethesda, Maryland, USA.

Study proves the effectiveness of Vfend for the treatment of candidemia

Using Vfend (voriconazole) for the treatment of nonneutropenic patients with candidemia, an often-fatal hospital-acquired bloodstream infection, is as effective as a regimen of two older antifungals and carries fewer serious side effects than that regimen.

Scalp cooling technology to fight cancer causing alopecia (hair loss) approved by the FDA

Paxman Coolers Limited announced today that The U.S. Food and Drug Administration (FDA) has cleared the company to market the Paxman Scalp Cooling System, a scalp cooling technology that was developed by a British family to reduce hair loss in breast cancer patients undergoing chemotherapy.

Read more Medical News

› Verified 6 days ago

Provider NameGerard J Burns
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1871783506
PECOS PAC ID: 9638225261
Enrollment ID: I20110316000071

News Archive

Leading organizations call for responsible use of antibiotics to combat rising drug resistance

In the lead-up to World Antibiotic Awareness Week (13-19 November 2017), the Food and Agriculture Organization of the United Nations, the World Health Organization and the World Organisation for Animal Health are together calling for responsible use of antibiotics in humans and animals to reduce the emergence of antibiotic resistance.

Uroglide technology could improve comfort for catheter users

A new pharmaceutical product that could significantly improve quality of life for catheter users all over the world is to be developed by Queen's University Belfast after it won a national award.

Conference reviews effects of tobacco products, underscores the importance of oral health

On September 14, 2018 AADR held the "Oral Health Effects of Tobacco Products: Science and Regulatory Policy" meeting in Bethesda, Maryland, USA.

Study proves the effectiveness of Vfend for the treatment of candidemia

Using Vfend (voriconazole) for the treatment of nonneutropenic patients with candidemia, an often-fatal hospital-acquired bloodstream infection, is as effective as a regimen of two older antifungals and carries fewer serious side effects than that regimen.

Scalp cooling technology to fight cancer causing alopecia (hair loss) approved by the FDA

Paxman Coolers Limited announced today that The U.S. Food and Drug Administration (FDA) has cleared the company to market the Paxman Scalp Cooling System, a scalp cooling technology that was developed by a British family to reduce hair loss in breast cancer patients undergoing chemotherapy.

Read more Medical News

› Verified 6 days ago

Provider NameLauren Mcdowell
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1265838296
PECOS PAC ID: 2466772272
Enrollment ID: I20150519001403

News Archive

Leading organizations call for responsible use of antibiotics to combat rising drug resistance

In the lead-up to World Antibiotic Awareness Week (13-19 November 2017), the Food and Agriculture Organization of the United Nations, the World Health Organization and the World Organisation for Animal Health are together calling for responsible use of antibiotics in humans and animals to reduce the emergence of antibiotic resistance.

Uroglide technology could improve comfort for catheter users

A new pharmaceutical product that could significantly improve quality of life for catheter users all over the world is to be developed by Queen's University Belfast after it won a national award.

Conference reviews effects of tobacco products, underscores the importance of oral health

On September 14, 2018 AADR held the "Oral Health Effects of Tobacco Products: Science and Regulatory Policy" meeting in Bethesda, Maryland, USA.

Study proves the effectiveness of Vfend for the treatment of candidemia

Using Vfend (voriconazole) for the treatment of nonneutropenic patients with candidemia, an often-fatal hospital-acquired bloodstream infection, is as effective as a regimen of two older antifungals and carries fewer serious side effects than that regimen.

Scalp cooling technology to fight cancer causing alopecia (hair loss) approved by the FDA

Paxman Coolers Limited announced today that The U.S. Food and Drug Administration (FDA) has cleared the company to market the Paxman Scalp Cooling System, a scalp cooling technology that was developed by a British family to reduce hair loss in breast cancer patients undergoing chemotherapy.

Read more Medical News

› Verified 6 days ago

Provider NameJohn Scarpitti
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1487958971
PECOS PAC ID: 0941485981
Enrollment ID: I20150624000457

News Archive

Leading organizations call for responsible use of antibiotics to combat rising drug resistance

In the lead-up to World Antibiotic Awareness Week (13-19 November 2017), the Food and Agriculture Organization of the United Nations, the World Health Organization and the World Organisation for Animal Health are together calling for responsible use of antibiotics in humans and animals to reduce the emergence of antibiotic resistance.

Uroglide technology could improve comfort for catheter users

A new pharmaceutical product that could significantly improve quality of life for catheter users all over the world is to be developed by Queen's University Belfast after it won a national award.

Conference reviews effects of tobacco products, underscores the importance of oral health

On September 14, 2018 AADR held the "Oral Health Effects of Tobacco Products: Science and Regulatory Policy" meeting in Bethesda, Maryland, USA.

Study proves the effectiveness of Vfend for the treatment of candidemia

Using Vfend (voriconazole) for the treatment of nonneutropenic patients with candidemia, an often-fatal hospital-acquired bloodstream infection, is as effective as a regimen of two older antifungals and carries fewer serious side effects than that regimen.

Scalp cooling technology to fight cancer causing alopecia (hair loss) approved by the FDA

Paxman Coolers Limited announced today that The U.S. Food and Drug Administration (FDA) has cleared the company to market the Paxman Scalp Cooling System, a scalp cooling technology that was developed by a British family to reduce hair loss in breast cancer patients undergoing chemotherapy.

Read more Medical News

› Verified 6 days ago

Provider NameKathleen Ann Oshea
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1407397920
PECOS PAC ID: 1456620301
Enrollment ID: I20170707002412

News Archive

Leading organizations call for responsible use of antibiotics to combat rising drug resistance

In the lead-up to World Antibiotic Awareness Week (13-19 November 2017), the Food and Agriculture Organization of the United Nations, the World Health Organization and the World Organisation for Animal Health are together calling for responsible use of antibiotics in humans and animals to reduce the emergence of antibiotic resistance.

Uroglide technology could improve comfort for catheter users

A new pharmaceutical product that could significantly improve quality of life for catheter users all over the world is to be developed by Queen's University Belfast after it won a national award.

Conference reviews effects of tobacco products, underscores the importance of oral health

On September 14, 2018 AADR held the "Oral Health Effects of Tobacco Products: Science and Regulatory Policy" meeting in Bethesda, Maryland, USA.

Study proves the effectiveness of Vfend for the treatment of candidemia

Using Vfend (voriconazole) for the treatment of nonneutropenic patients with candidemia, an often-fatal hospital-acquired bloodstream infection, is as effective as a regimen of two older antifungals and carries fewer serious side effects than that regimen.

Scalp cooling technology to fight cancer causing alopecia (hair loss) approved by the FDA

Paxman Coolers Limited announced today that The U.S. Food and Drug Administration (FDA) has cleared the company to market the Paxman Scalp Cooling System, a scalp cooling technology that was developed by a British family to reduce hair loss in breast cancer patients undergoing chemotherapy.

Read more Medical News

› Verified 6 days ago

Provider NameTatanisha A Hason
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1013420298
PECOS PAC ID: 6406113026
Enrollment ID: I20171206001269

News Archive

Leading organizations call for responsible use of antibiotics to combat rising drug resistance

In the lead-up to World Antibiotic Awareness Week (13-19 November 2017), the Food and Agriculture Organization of the United Nations, the World Health Organization and the World Organisation for Animal Health are together calling for responsible use of antibiotics in humans and animals to reduce the emergence of antibiotic resistance.

Uroglide technology could improve comfort for catheter users

A new pharmaceutical product that could significantly improve quality of life for catheter users all over the world is to be developed by Queen's University Belfast after it won a national award.

Conference reviews effects of tobacco products, underscores the importance of oral health

On September 14, 2018 AADR held the "Oral Health Effects of Tobacco Products: Science and Regulatory Policy" meeting in Bethesda, Maryland, USA.

Study proves the effectiveness of Vfend for the treatment of candidemia

Using Vfend (voriconazole) for the treatment of nonneutropenic patients with candidemia, an often-fatal hospital-acquired bloodstream infection, is as effective as a regimen of two older antifungals and carries fewer serious side effects than that regimen.

Scalp cooling technology to fight cancer causing alopecia (hair loss) approved by the FDA

Paxman Coolers Limited announced today that The U.S. Food and Drug Administration (FDA) has cleared the company to market the Paxman Scalp Cooling System, a scalp cooling technology that was developed by a British family to reduce hair loss in breast cancer patients undergoing chemotherapy.

Read more Medical News

› Verified 6 days ago

Provider NameKelly Leigh Mission
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1144551276
PECOS PAC ID: 3375702327
Enrollment ID: I20190426000225

News Archive

Leading organizations call for responsible use of antibiotics to combat rising drug resistance

In the lead-up to World Antibiotic Awareness Week (13-19 November 2017), the Food and Agriculture Organization of the United Nations, the World Health Organization and the World Organisation for Animal Health are together calling for responsible use of antibiotics in humans and animals to reduce the emergence of antibiotic resistance.

Uroglide technology could improve comfort for catheter users

A new pharmaceutical product that could significantly improve quality of life for catheter users all over the world is to be developed by Queen's University Belfast after it won a national award.

Conference reviews effects of tobacco products, underscores the importance of oral health

On September 14, 2018 AADR held the "Oral Health Effects of Tobacco Products: Science and Regulatory Policy" meeting in Bethesda, Maryland, USA.

Study proves the effectiveness of Vfend for the treatment of candidemia

Using Vfend (voriconazole) for the treatment of nonneutropenic patients with candidemia, an often-fatal hospital-acquired bloodstream infection, is as effective as a regimen of two older antifungals and carries fewer serious side effects than that regimen.

Scalp cooling technology to fight cancer causing alopecia (hair loss) approved by the FDA

Paxman Coolers Limited announced today that The U.S. Food and Drug Administration (FDA) has cleared the company to market the Paxman Scalp Cooling System, a scalp cooling technology that was developed by a British family to reduce hair loss in breast cancer patients undergoing chemotherapy.

Read more Medical News

› Verified 6 days ago

Provider NameRochelle Howell
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1689384158
PECOS PAC ID: 0749652733
Enrollment ID: I20230221003060

News Archive

Leading organizations call for responsible use of antibiotics to combat rising drug resistance

In the lead-up to World Antibiotic Awareness Week (13-19 November 2017), the Food and Agriculture Organization of the United Nations, the World Health Organization and the World Organisation for Animal Health are together calling for responsible use of antibiotics in humans and animals to reduce the emergence of antibiotic resistance.

Uroglide technology could improve comfort for catheter users

A new pharmaceutical product that could significantly improve quality of life for catheter users all over the world is to be developed by Queen's University Belfast after it won a national award.

Conference reviews effects of tobacco products, underscores the importance of oral health

On September 14, 2018 AADR held the "Oral Health Effects of Tobacco Products: Science and Regulatory Policy" meeting in Bethesda, Maryland, USA.

Study proves the effectiveness of Vfend for the treatment of candidemia

Using Vfend (voriconazole) for the treatment of nonneutropenic patients with candidemia, an often-fatal hospital-acquired bloodstream infection, is as effective as a regimen of two older antifungals and carries fewer serious side effects than that regimen.

Scalp cooling technology to fight cancer causing alopecia (hair loss) approved by the FDA

Paxman Coolers Limited announced today that The U.S. Food and Drug Administration (FDA) has cleared the company to market the Paxman Scalp Cooling System, a scalp cooling technology that was developed by a British family to reduce hair loss in breast cancer patients undergoing chemotherapy.

Read more Medical News

› Verified 6 days ago

Provider NameJoseph B Phillips
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1003287038
PECOS PAC ID: 5092169649
Enrollment ID: I20230929002667

News Archive

Leading organizations call for responsible use of antibiotics to combat rising drug resistance

In the lead-up to World Antibiotic Awareness Week (13-19 November 2017), the Food and Agriculture Organization of the United Nations, the World Health Organization and the World Organisation for Animal Health are together calling for responsible use of antibiotics in humans and animals to reduce the emergence of antibiotic resistance.

Uroglide technology could improve comfort for catheter users

A new pharmaceutical product that could significantly improve quality of life for catheter users all over the world is to be developed by Queen's University Belfast after it won a national award.

Conference reviews effects of tobacco products, underscores the importance of oral health

On September 14, 2018 AADR held the "Oral Health Effects of Tobacco Products: Science and Regulatory Policy" meeting in Bethesda, Maryland, USA.

Study proves the effectiveness of Vfend for the treatment of candidemia

Using Vfend (voriconazole) for the treatment of nonneutropenic patients with candidemia, an often-fatal hospital-acquired bloodstream infection, is as effective as a regimen of two older antifungals and carries fewer serious side effects than that regimen.

Scalp cooling technology to fight cancer causing alopecia (hair loss) approved by the FDA

Paxman Coolers Limited announced today that The U.S. Food and Drug Administration (FDA) has cleared the company to market the Paxman Scalp Cooling System, a scalp cooling technology that was developed by a British family to reduce hair loss in breast cancer patients undergoing chemotherapy.

Read more Medical News

› Verified 6 days ago

News Archive

Leading organizations call for responsible use of antibiotics to combat rising drug resistance

In the lead-up to World Antibiotic Awareness Week (13-19 November 2017), the Food and Agriculture Organization of the United Nations, the World Health Organization and the World Organisation for Animal Health are together calling for responsible use of antibiotics in humans and animals to reduce the emergence of antibiotic resistance.

Uroglide technology could improve comfort for catheter users

A new pharmaceutical product that could significantly improve quality of life for catheter users all over the world is to be developed by Queen's University Belfast after it won a national award.

Conference reviews effects of tobacco products, underscores the importance of oral health

On September 14, 2018 AADR held the "Oral Health Effects of Tobacco Products: Science and Regulatory Policy" meeting in Bethesda, Maryland, USA.

Study proves the effectiveness of Vfend for the treatment of candidemia

Using Vfend (voriconazole) for the treatment of nonneutropenic patients with candidemia, an often-fatal hospital-acquired bloodstream infection, is as effective as a regimen of two older antifungals and carries fewer serious side effects than that regimen.

Scalp cooling technology to fight cancer causing alopecia (hair loss) approved by the FDA

Paxman Coolers Limited announced today that The U.S. Food and Drug Administration (FDA) has cleared the company to market the Paxman Scalp Cooling System, a scalp cooling technology that was developed by a British family to reduce hair loss in breast cancer patients undergoing chemotherapy.

Read more News

› Verified 6 days ago


Clinic/Center in Glassboro, NJ

Rowan Wellness Center - Family Medicine
Primary Care Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 201 Mullica Hill Rd, Winans Hall, Glassboro, NJ 08028
Phone: 856-256-4333    Fax: 856-256-4427
Underwood-memorial Hospital
Primary Care Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 1120 Delsea Dr N, Glassboro, NJ 08028
Phone: 856-582-0500    Fax: 856-582-0163
Completecare Health Network
Primary Care Clinic
Medicare: Medicare Enrolled
Practice Location: 715 Delsea Dr N, Units 3, 4, & 5, Glassboro, NJ 08028
Phone: 856-451-4700    Fax: 856-575-0818
Jon S Heist Do Pa
Primary Care Clinic
Medicare: Medicare Enrolled
Practice Location: 361 N Main St, Glassboro, NJ 08028
Phone: 856-881-8618    Fax: 856-881-5368
American Workcare, Pc
Primary Care Clinic
Medicare: Medicare Enrolled
Practice Location: 1125 North Delsea Dr, Glassboro, NJ 08028
Phone: 856-218-7600    Fax: 856-218-7800
Kennedy Health Alliance
Primary Care Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 601 N Main St, Glassboro, NJ 08028
Phone: 844-542-2273    

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.